Medical, Blood, Science, Biology, Technology.
suggest that LIG biosensors could be considered for point-of-care diagnostics in the near future. With the combination of aptamers and our new graphene-based electrode, commercialization of electrochemistry immunoassays can be possible in the next 5–10 years.” Reference Authors: Ajay Kumar Yagati